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Abstract
Purpose of review—The vermiculite ore formerly mined in Libby, Montana, contains 
asbestiform amphibole fibers of winchite, richterite, and tremolite asbestos. Because of the public 
health impact of widespread occupational and nonoccupational exposure to amphiboles in Libby 
vermiculite, numerous related studies have been published in recent years. Here we review current 
research related to this issue.
Recent findings—Excess morbidity and mortality classically associated with asbestos exposure 
have been well documented among persons exposed to Libby vermiculite. Excess morbidity and 
mortality have likewise been documented among persons with only nonoccupational exposure. A 
strong exposure–response relationship exists for many malignant and nonmalignant outcomes and 
the most common outcome, pleural plaques, may occur at low lifetime cumulative exposures.
Summary—The public health situation related to Libby, Montana, has led to huge investments in 
public health actions and research. The resulting studies have added much to the body of 
knowledge concerning health effects of exposures to Libby amphibole fibers specifically and 
asbestos exposure in general.
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INTRODUCTION
A vermiculite mine and mill located near Libby, Montana, operated from the early 1920s 
until 1990. Vermiculite is a naturally occurring laminar aluminum-iron-magnesium silicate. 
It expands when heated, and has been employed in many applications, such as loose-fill attic 
insulation, soil additive, and carrier for various chemicals, including herbicides, insecticides, 
and fertilizers [1]. Vermiculite from other sources is not known to be associated with any 
substantial adverse health effects [2,3]; however, the vermiculite ore mined in Libby 
contained elongate mineral particles identified as a mixture of asbestiform amphiboles, 
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including winchite, richterite, and tremolite asbestos [4]. Not only were workers at the mine 
and mill exposed, but the vermiculite was used in Libby for covering ball fields and outdoor 
athletic tracks, as loose-fill insulation in buildings, and in gardening activities [5]. This 
resulted in widespread contamination of the Libby community with asbestos. In addition, the 
fact that a very large estimated number of homes were insulated with Libby vermiculite 
represents an ongoing potential hazard. Moreover, Libby vermiculite was shipped 
throughout the US to more than 200 domestic processing and receiving facilities [6]. 
Interestingly, the first identification by public health authorities of pulmonary abnormalities 
associated with Libby vermiculite concerned exposures outside of Libby. Benign pleural 
effusions were identified among 12 workers in a vermiculite processing plant in Marysville, 
Ohio, which received most of its vermiculite from Libby [1]. This review will focus on the 
main nonmalignant and malignant respiratory outcomes associated with exposure to Libby 
vermiculite, with emphasis on recent findings.
NONMALIGNANT RESPIRATORY OUTCOMES
The results of several studies have shown excessive mortality attributed to nonmalignant 
respiratory disease (NMRD) among sub-cohorts of Libby mine and mill workers. In a study 
commissioned by the mine owners, McDonald et al. [7] found an elevated overall 
standardized mortality ratio (SMR) of 2.55 for NMRD among mine workers employed for at 
least 1 year. NMRD mortality was clearly associated with exposure to Libby vermiculite, 
with SMRs of 3.36 for 10–19 years and 5.30 for more than 20 years since first employment 
[7]. In another study of Libby mine and mill workers, researchers from the National Institute 
for Occupational Safety and Health (NIOSH) found a SMR for NMRD of 2.43 [95% 
confidence interval (CI) 1.48–3.75] [8]. A subsequent expansion and updating of this Libby 
worker cohort, including all white men who worked in the Libby plant from 1935 to 1981, 
found a SMR for NMRD of 2.4 (95% CI 2.0–2.9), again demonstrating an obvious 
correlation with exposure duration: 2.1 for less than 1 year, 2.4 for 1–9.9 years, and 3.6 for 
more than 10 years [9]. More recently, these results were corroborated by an independent 
analysis [10■]. In addition, McDonald et al. [11] also updated their cohort study to 1998, 
finding an overall SMR for NMRD of 3.09 (95% CI 2.30–4.06), also associated with 
cumulative exposure. Finally, Larson et al. [12■] updated mortality in the cohort of Libby 
vermiculite workers through 2006 and, using a multiple cause-of-death approach with an 
internal comparison, modeled the exposure–response relationship between cumulative 
exposure to Libby amphibole fiber and select causes of mortality. SMR results for NMRD 
were similar to previous studies [SMR = 2.4 (95% CI 2.2–2.6)]. Using quartiles of 
cumulative fiber exposure (CFE) (f/cc-y) in a categorical model, the rate ratios (and 95% 
CIs) for NMRD were 1.4 (0.9–2.1), 1.8 (1.3–2.7), and 2.5 (1.7–3.6) for 1.4 to below 8.6, 8.6 
to below 44.0, and at least 44.0 f/cc-y, respectively [12■]. Although most of these studies 
have a long period of vital status follow-up, important limitations include the potential for 
exposure misclassification, dependence on death certificate information, and the absence of 
smoking data.
A few studies have specifically evaluated the mortality from asbestosis among persons 
exposed to Libby vermiculite. Sullivan [9] reported 22 deaths from asbestosis (expected = 
0.13 deaths) among 1672 Libby vermiculite workers during 1960–2001, for a SMR of 165.8 
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(95% CI 103.9–251.1); this study revealed a striking association of asbestosis mortality with 
levels of cumulative exposure and duration of exposure. A recent update [12■] of that cohort 
also demonstrated an elevated SMR for asbestosis of 142.8 (95% CI 111.1–180.8) and a rate 
ratio of 11.8 (95% CI 4.9–28.7) in the highest exposure group (44.0 f/cc-y).
A study [13■] of Libby residents who were 18 years of age or less when the vermiculite 
mine closed in 1990 identified self-reported respiratory symptoms that were associated with 
several vermiculite exposure pathways. Prevalences of several of these, including cough 
(10.8%), shortness of breath (14.5%), and coughing up bloody phlegm (5.9%), were higher 
than expected based on comparison with national population rates from the 2001 to 2002 
National Health and Nutrition Examination Survey (NHANES), controlling for sex, age, 
smoking status, and family smoking status.
RADIOGRAPHIC PLEURAL ABNORMALITIES
The most common pleural abnormalities associated with asbestos exposure are localized 
pleural thickening (pleural plaques) and diffuse pleural thickening, either of which can be 
accompanied by pleural calcification [14]. These are also commonly found among persons 
with occupational and nonoccupational exposure to Libby vermiculite. Most 
epidemiological studies use the International Labour Office (ILO) International 
Classification of Radiographs of Pneumoconioses [15] to determine the presence and 
location of pleural abnormalities in asbestos-exposed populations.
In an early radiographic survey conducted by NIOSH researchers [16], the prevalence of any 
pleural abnormality (pleural plaque or diffuse pleural thickening of the chest wall, 
diaphragm, or other site, excluding costophrenic angle obliteration) was 15.2% among 184 
active Libby mine workers, with a statistically significant association with CFE. The 
prevalence of pleural abnormalities of the chest wall was 13.0%. In another study of the 
Libby mining operation, McDonald et al. [17] found a comparable prevalence of 15.9% 
pleural abnormalities of the chest wall among 164 active miners; the corresponding 
prevalence among 80 former mine workers was 52.5%.
As part of the federal response to the widespread asbestos contamination in Libby, the 
Agency for Toxic Substances and Disease Registry (ATSDR) offered health screenings for 
the population. A total of 6668 persons participated in radiographic screening during 2000–
2001. An exposure–response relationship was evident between exposure pathways and the 
prevalence of pleural abnormalities, which was 51% among former mine workers, 23% 
among household contacts of former workers, and 14% among other Libby residents [5]. In 
another round of screenings conducted in 2003–2007, with the participation of 2954 
persons, the prevalence of pleural abnormalities was similar: 53, 24, and 16%, respectively, 
for the previously mentioned exposure categories (Helgerson S, personal communication).
A follow-up study [18] re-evaluated the chest radiographic status of the original 1980 
Marysville worker cohort [1] 25 years after their last exposure to Libby vermiculite. The 
prevalence of pleural changes among the 280 participants was 28.7%. A significant trend of 
increasing prevalence of localized pleural changes with increasing cumulative exposure was 
observed among Marysville workers. Further, prevalence of pleural abnormalities was 
Antao et al. Page 3













associated with very low lifetime cumulative exposures, even among persons with less than 
1 f/cc-y [18].
Several factors may affect the accurate detection of pleural abnormalities. One concern with 
using conventional radiographs to identify asbestos-related diseases is their apparent lack of 
sensitivity and specificity for detecting these lesions. Using high-resolution computed 
tomography (HRCT) of the chest, Muravov et al. [19] found pleural abnormalities in 28% of 
353 Libby residents whose radiographs had been found to be ‘indeterminate’ based on 
classifications by three B Readers, indicating standard chest radiography may not be the 
optimal method for detecting subtle pleural abnormalities. However, an important limitation 
of that study was the lack of HRCTs of people with totally negative or totally positive chest 
radiographs, which may have restricted its conclusions. Screening the Libby population has 
also shown that pleural fat can be mistaken for pleural plaque on chest radiographs [20]. 
Among participants of the screening program in Libby, 32% were obese; hence there is a 
need to control for the potential confounding effect of body mass index in analyses relating 
to pleural thickening in asbestos-exposed populations [5]. Another issue is the latency 
between initial exposure to asbestos and detection of associated pleural abnormalities in 
chest radiographs. By conducting a study that used retrospective analysis of a series of chest 
radiographs of Libby vermiculite workers, Larson et al. [21■] recently demonstrated that 
this period may be shorter than usually reported for asbestos-exposed workers (i.e. 20 years 
for pleural plaques [14]). The median latency for detecting localized pleural thickening was 
8.6 years, ranging from 1.4 to 14.7 years. For diffuse pleural thickening, the median (range) 
latency from hire date was 27 years (10.7–29.8 years). Clinicians should be aware that 
latencies for plaque may be shorter than has been reported previously for asbestos-exposed 
workers, and that plaque can occur in pediatric patients.
Recent findings from a large community-based cohort study in Libby [22] demonstrated a 
statistically significant association between localized pleural thickening and restrictive 
spirometry. In addition, among patients with restrictive spirometry, the odds of functional 
impairment increased with extent of localized pleural thickening.
RADIOGRAPHIC PARENCHYMAL ABNORMALITIES
Asbestosis is the interstitial pneumonitis and fibrosis caused by inhalation of asbestos fibers; 
its prevalence is influenced by duration and intensity of exposure [14]. The radiographic 
presentation of asbestosis is usually of small irregular parenchymal opacities in the lower 
lobes bilaterally. Most epidemiological studies use the International Labour Office (ILO) 
International Classification of Radiographs of Pneumoconioses [15] to determine the 
presence and extent (profusion) of parenchymal abnormalities in asbestos-exposed 
populations.
The first studies to describe the prevalence of parenchymal abnormalities in Libby 
vermiculite workers found it to range from 10 to 18% and to be strongly associated with 
CFE [16,17]. Peipins et al. [5] reported that the overall prevalence of parenchymal 
abnormalities among 6668 individuals screened by ATSDR in 2000–2001 was 0.8% and 
varied among different exposure groups: 3.8% for former mine workers, 1.2% for household 
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contacts, and 0.5% for other residents. These prevalences were somewhat higher among 
participants of the second ATSDR screening activity (13.3, 2.5, and 4%, respectively), 
possibly due to differences in radiographic reading methods, such as the number of B 
Readers used (Helgerson S, personal communication). Of the 280 Marysville workers 
followed up 25 years after their last exposure to Libby vermiculite, eight (2.9%) had 
parenchymal abnormalities consistent with asbestosis [18]. The mean CFE for these eight 
was significantly greater than that for Marysville workers with normal radiographs and also 
significantly greater than that for Marysville workers with pleural abnormalities only.
Among asbestos-related diseases, radiographic parenchymal abnormalities are generally 
more strongly associated with lung function defects, specifically restrictive pattern, than are 
radiographic pleural abnormalities. As expected, in a recent analysis of 6475 screening 
participants [22], we found that restrictive spirometry was strongly associated with 
parenchymal abnormalities [odds ratio (OR) 2.9; 95% CI 1.4–6.0], after controlling for age, 
sex, smoking status, and body mass index.
MALIGNANT DISEASES
According to the International Agency for Research on Cancer (IARC), all forms of asbestos 
are carcinogenic to humans. In addition, mineral substances (e.g. talc or vermiculite) that 
contain asbestos should also be regarded as carcinogenic to humans. The most common 
malignancies associated with asbestos exposure are lung cancer and malignant 
mesothelioma of the pleura, peritoneum, and other sites. More recently, IARC deemed that 
cancers of the larynx and ovary were also caused by asbestos exposure, and there was 
limited evidence for associations between asbestos exposure and cancers of the colorectum, 
pharynx, and stomach [23].
All epidemiological studies that have assessed the association between exposure to the 
Libby vermiculite and cancers of the respiratory tract have found a strong relationship. 
Using the US white male population as comparison, Amandus and Wheeler [8] described a 
SMR of 2.23 (95% CI 1.36–3.45) for respiratory cancers, and McDonald et al. [7] found a 
corresponding SMR of 2.45. Both studies observed statistically significant associations with 
CFE and time since first exposure. When Montana controls were used instead of national US 
rates, the SMR increased to 3.03 in the latter study [7]. An update of that cohort to 1999, 
which doubled the number of respiratory cancers in the analysis, found a SMR of 2.40 (95% 
CI 1.74–3.22) [11]. Similarly, Sullivan [9] found 89 cases of cancer of the trachea, 
bronchus, or lung, for a SMR of 1.7 (95% CI 1.4–2.1); in addition, two deaths from 
mesothelioma (in 1999–2001) and four deaths from cancer of the pleura were identified, for 
SMRs of 15.1 (95% CI 1.8–54.4) and 23.3 (95% CI 6.3–59.5), respectively. Both 
cumulative exposure and exposure duration were statistically significant predictors of lung 
cancer mortality in that study. A shortcoming of these mortality studies is that the analyses 
have not been formally controlled for cigarette smoking.
A case series of malignant mesothelioma associated with environmental exposure in Libby 
described a total of 11 patients (10 pleural, 1 peritoneal) diagnosed in 1995–2006. No 
occupational exposure was reported in 9 of these 11 patients; many had vermiculite 
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insulation in their homes, lived in the vicinity of vermiculite processing facilities, or were 
household contacts of workers [24].
As mentioned earlier, Libby vermiculite was shipped to many processing facilities across the 
US. In an attempt to estimate the burden of asbestos-related disease in these areas, Horton et 
al. [25] identified 262 sites in 40 states that processed Libby vermiculite. According to death 
certificates, SMRs for cancer of the pleura and peritoneum were elevated in Portland, OR; 
Utica, NY; Hamilton Township, NY; Jersey City, NJ; Newark, NJ; Tampa, FL; and 
Milwaukee, WI. In addition, standardized incidence ratios, calculated using cancer registry 
data, were elevated in Jersey City, NJ; Kearny, NJ; Camden, NJ; Kenosha, WI; Portland, 
OR; Jefferson Parish, LA; and six pooled sites in IL [25]. Although this ecological study 
cannot directly link exposure to Libby vermiculite with asbestos-related disease, it suggests 
a need for additional studies in these areas.
More recently, Larson et al. [12■] demonstrated SMRs for lung cancer among the Libby 
vermiculite worker cohort to be 1.6 (95% CI 1.3–2.0). Exposure–response analysis of that 
updated cohort showed that rate ratios for lung cancer increased monotonically with 
increasing CFE, becoming statistically significant for the fourth quartile: with a CFE at least 
44 f/cc-y the rate ratios were 3.2 (95% CI 1.8–5.3) [12■]. Bias analysis suggested that 
cigarette smoking had minimal impact on the exposure–response relationships in this study.
CONCLUSION
Strong evidence exists to support the association between exposure to asbestiform 
amphibole fibers in Libby vermiculite and the occurrence of asbestos-related diseases, 
especially nonmalignant pleural abnormalities, lung cancer, and malignant mesothelioma 
(Table 1). The studies presented here may share limitations common in other 
epidemiological studies: some of them lack appropriate comparison populations, whereas 
others are limited in their ability to control for the potential influence of confounders such as 
cigarette smoking. Nevertheless, the evidence for causation of disease from Libby 
amphibole exposure includes several factors: similarity and consistency of results among 
studies; monotonically increasing exposure–response pattern across studies; and temporal 
association between start and duration of exposure and disease onset.
The widespread asbestos contamination in Libby has prompted an unprecedented public 
health response, with large-scale – and still ongoing – health screening supported by 
ATSDR, and the recent declaration of a public health emergency by the Environmental 
Protection Agency [26].
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• Exposure to asbestiform amphibole fibers in Libby vermiculite is associated 
with nonmalignant and malignant asbestos-related diseases.
• Strong exposure–response relationships exist for many of these health outcomes.
• The impact of asbestos contamination in this community continues to pose a 
substantial challenge in terms of public health policy.
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